The effects of excitotoxic hippocampal lesions in rats on risperidone- and olanzapine-induced locomotor suppression

Neuropsychopharmacology

Volumn 27, Issue 6, 2002, Pages 930-938

  Bardgett, Mark E ^a,b   Humphrey, William M ^a   Csernansky, John G ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTHERN KENTUCKY UNIVERSITY   (United States)

Author keywords

Amphetamine; Antipsychotic; Grooming; Haloperidol; Hippocampus; Locomotion

Indexed keywords

AMPHETAMINE; KAINIC ACID; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN NERVE CELL; CELL LOSS; CONTROLLED STUDY; DATA ANALYSIS; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; HIPPOCAMPUS; LOCOMOTION; MALE; NERVE CELL LESION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BENZODIAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID AGONISTS; HIPPOCAMPUS; KAINIC ACID; MALE; MOTOR ACTIVITY; PIRENZEPINE; RATS; RATS, SPRAGUE-DAWLEY; RISPERIDONE;

EID: 0036897926     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(02)00376-7     Document Type: Article

References (34)

1. Arnt J. Differential effects of classical and newer antipsychotics on the hypermotility induced by two dose levels of D-amphetamine. Eur J Pharmacol. 283:1995;55-62.
2. Bardgett M.E., Jackson J.L., Taylor G.T., Csernansky J.G. Kainic acid decreases hippocampal neuronal number and increases dopamine receptor binding in the nucleus accumbens. An animal model of schizophrenia Behav Brain Res. 70:1995;153-164.
3. Bardgett M.E., Csernansky J.G. Antipsychotic drug action after lesions to the hippocampus or prefrontal cortex. Csernansky J.G. Handbook of Experimental Pharmacology. Antipsychotics, vol 120:1996;267-288 Springer-Verlag, Heidelberg.
4. Bardgett M.E., Jacobs P.S., Jackson J.L., Csernansky J.G. Kainic acid lesions enhance locomotor responses to novelty, saline, amphetamine, and MK-801. Behav Brain Res. 84:1997;47-55. a.
5. Bardgett M.E., Salaris S.L., Jackson J.L., Harding J., Csernansky J.G. The effects of kainic acid lesions on dopaminergic responses to haloperidol and clozapine. Psychopharmacology (Berl). 133:1997;142-151. b.
6. Bardgett M.E., Jackson J.L., Taylor B.M., Csernansky J.G. The effects of kainic acid lesions on locomotor responses to haloperidol and clozapine. Psychopharmacology (Berl). 135:1998;270-278.
7. Bardgett M.E., Henry J.D. Locomotor activity and accumbens fos expression driven by hippocampal stimulation requires D1 and D2 receptors. Neurosci. 94:1999;59-70.
8. Brog J.S., Salyapongse A., Deutch A.Y., Zahm D.S. The patterns of afferent innervation of the core and shell in the "accumbens" part of the rat ventral striatum. Immunohistochemical detection of retrogradely transported fluoro-gold J Comp Neurol. 338:1993;255-278.
9. Bymaster F.P., Calligaro D.O., Falcone J.F., Marsh R.D., Moore N.A., Tye N.C., Seeman P., Wong D.T. Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology. 14:1996;87-96.
10. Carr D.B., Sesack S.R. Hippocampal afferents to the rat prefrontal cortex. Synaptic targets and relation to dopamine terminals J Comp Neurol. 369:1996;1-15.
11. Cohen J.D., Barch D.M., Carter C., Servan-Schreiber D. Context-processing deficits in schizophrenia. converging evidence from three theoretically motivated cognitive tasks J Abnorm Psychol. 108:1999;120-133.
12. Colangelo V., Di Grezia R., Passarelli F., Musicco M., Ponteri F.E., Orzi F. Differential effects of acute administration of clozapine or haloperidol on local cerebral glucose utilization in the rat. Brain Res. 768:1997;273-278.
13. Csernansky J.G., Bardgett M.E. Limbic-cortical neuronal damage and the pathophysiology of schizophrenia. Schiz Bull. 24:1998;231-248.
14. Csernansky J.G., Csernansky C.A., Kogelman L., Montgomery E.M., Bardgett M.E. Progressive neurodegeneration after ICV kainic acid administration in rats. Implications for schizophrenia? Biol Psychiatry. 44:1998;1143-1150.
15. Csernansky J.G., Wang L., Joshi S., Miller J.P., Gado M., Kido D., McKeel D., Morris J.C., Miller M.I. Early DAT is distinguished from aging by high-dimensional mapping of the hippocampus. Dementia of the Alzheimer type. Neurology. 55:2000;1636-1643.
16. Darracq L., Blanc S., Glowinski J., Tassin J.-P. Importance of the noradrenaline-dopamine coupling in the locomotor activating effects of D-amphetamine. J Neurosci. 18:1998;2729-2739.
17. Deutch A.Y. Sites and mechanisms of action of antipsychotic drugs as revealed immediate early gene expression. Csernansky J.G. Handbook of Experimental Pharmacology. Antipsychotics, vol 102:1996;117-162 Springer-Verlag, Heidelberg.
18. Huang Y.-H., Tsai S.-J., Huang H.-J., Sim C.-B. The effect of acute administration of risperidone on local cerebral glucose administration. Eur J Pharmacol. 370:1999;257-261.
19. Joyce J.N., Lexow N., Bird E., Winokur A. Organization of dopamine D1 and D2 receptors in the human striatum. receptor autoradiographic studies in Huntington's disease and schizophrenia Synapse. 2:1988;546-557.
20. Marder S.R. An approach to treatment resistance in schizophrenia. Br J Psychiatry. 37:1999;19-22.
21. McCarley R.W., Wible C.G., Frumin M., Hirayasu Y., Levitt J.J., Fischer I.A., Shenton M.E. MRI anatomy of schizophrenia. Biol Psychiatry. 45:1999;1099-1119.
22. Mittleman G., Jones G.H., Robbins T.W. Sensitization of amphetamine-stereotypy reduces plasma corticosterone. Implications for stereotypy as a coping response Behav Neur Biol. 56:1991;170-182.
23. Mittleman G., LeDuc P.A., Whishaw I.Q. The role of D1 and D2 receptors in the heightened locomotion induced by direct and indirect dopamine agonists in rats with hippocampal damage. An animal analogue of schizophrenia Behav Brain Res. 55:1993;253-267.
24. Nadler J.V., Perry B.W., Cotman C. Preferential vulnerability of hippocampus to intraventricular kainic acid. McGeer E.G., Olney J.W., McGeer P.L. Kainic Acid as a Tool in Neurobiology. 1st ed:1978;219-237 Raven Press, New York.
25. Ogren S.O. The behavioral pharmacology of typical and atypical antipsychotic drugs. Csernansky J.G. Handbook of Experimental Pharmacology. Antipsychotics:1996;225-266 Springer-Verlag, Heidelberg.
26. Park S., Holzman P.S. Schizophrenics show spatial working memory deficits. Arch Gen Psychiatry. 49:1992;975-982.
27. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 1986;Academic Press, Sydney.
28. Prosser E.S., Pruthi R., Csernansky J.G. Differences in the time course of dopaminergic supersensitivity following chronic administration of haloperidol, molindone, or sulpiride. Psychopharmacology. 99:1989;109-116.
29. Roe D.L., Bardgett M.E., Csernansky C.A., Csernansky J.G. Induction of fos protein by antipsychotic drugs in rat brain following kainic acid-induced limbic-cortical neuronal loss. Psychopharmacology (Berl). 138:1998;151-158.
30. Schotte A., Janssen P.F.M., Megens A.A.H.P., Leysen J.E. Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography. Brain Res. 631:1993;191-202.
31. Sesack S.R., Pickel V.M. In the rat nucleus accumbens, hippocampal and catecholaminergic terminals converge on spiny neurons and are in apposition to each other. Brain Res. 527:1990;266-279.
32. Tollefson G.D., Kuntz A.J. Review of recent clinical studies with olanzapine. Br J Psychiatry. 37:1999;30-35.
33. Yin H., Bardgett M.E., Csernansky J.G. Kainic acid lesions disrupt fear-mediated memory processes. Neurobiol Learn Mem. 77:2002;389-401.
34. Wong D.F., Pearlson G.D., Tune L.E., Young L.T., Meltzer C.C., Dannals R.F., Ravert H.T., Reith J., Kuhar M.J., Gjedde A. Quantification of neuroreceptors in the living human brain. IV Effect of aging and elevations of D. 2-like(receptors in schizophrenia and bipolar illness. J Cereb Blood Flow Metab 17):1997;331-342.